A Dual Effort Choice paradigm reveals pharmacological divergence between intrinsic and extrinsic motivation within the same task environment

Motivation loss is a transdiagnostic symptom, prevalent across neuropsychiatric and neurodegenerative diseases. Current treatments fail to effectively treat this symptom domain, giving it significant clinical importance. The fields of neuroscience and drug development have primarily focused on extrinsic motivation, whereby an animal must perform an action to receive an external food or water-based reward. However, many of our everyday activities are facilitated by intrinsic motivation, where completing an action is inherently rewarding. By utilising tasks focused only on extrinsic motivation, we may miss critical neurobiological and therapeutic differences between motivation types. Previous work has shown divergence in drug effect between extrinsic and intrinsic motivation tasks across a wide range of clinically-used drugs, indicating translationally-relevant differences across motivation domains that warrant further study. Therefore, the aim of this work was first to develop a task capable of simultaneously quantifying intrinsic and extrinsically motivated behaviour within the same task environment. Secondly, to use this task to further investigate this neurochemical divergence by examining a wide range of clinically-relevant drugs within this new task context. Here, we find that a pharmacological reduction in dopaminergic signalling reduced motivation across both extrinsic and intrinsic options within the new task, though this effect was mechanism dependent. In contrast, acute serotonergic and dopaminergic signalling increase produced a more heterogenous pattern, indicating nuanced mechanistic differences even when presented in the same task environment. Therefore, this task provides a new approach for characterising drug effects on distinct forms of motivated behaviour that may go unnoticed using conventional assays.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.12.766115
Primary Topic
Neurotransmitter Receptor Influence on Behavior
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

A Dual Effort Choice paradigm reveals pharmacological divergence between intrinsic and extrinsic motivation within the same task environment

Megan G. Jackson, Peter Salisbury, Emma S. J. Robinson, Foteini Xeni et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Neurotransmitter Receptor Influence on Behavior
preprint

A Dual Effort Choice paradigm reveals pharmacological divergence between intrinsic and extrinsic motivation within the same task environment

Megan G. Jackson, Peter Salisbury, Emma S. J. Robinson, Foteini Xeni, Caterina Marangoni, Eleanor W. Grayson, Froso Fachouridou
preprint en

Abstract

Motivation loss is a transdiagnostic symptom, prevalent across neuropsychiatric and neurodegenerative diseases. Current treatments fail to effectively treat this symptom domain, giving it significant clinical importance. The fields of neuroscience and drug development have primarily focused on extrinsic motivation, whereby an animal must perform an action to receive an external food or water-based reward. However, many of our everyday activities are facilitated by intrinsic motivation, where completing an action is inherently rewarding. By utilising tasks focused only on extrinsic motivation, we may miss critical neurobiological and therapeutic differences between motivation types. Previous work has shown divergence in drug effect between extrinsic and intrinsic motivation tasks across a wide range of clinically-used drugs, indicating translationally-relevant differences across motivation domains that warrant further study. Therefore, the aim of this work was first to develop a task capable of simultaneously quantifying intrinsic and extrinsically motivated behaviour within the same task environment. Secondly, to use this task to further investigate this neurochemical divergence by examining a wide range of clinically-relevant drugs within this new task context. Here, we find that a pharmacological reduction in dopaminergic signalling reduced motivation across both extrinsic and intrinsic options within the new task, though this effect was mechanism dependent. In contrast, acute serotonergic and dopaminergic signalling increase produced a more heterogenous pattern, indicating nuanced mechanistic differences even when presented in the same task environment. Therefore, this task provides a new approach for characterising drug effects on distinct forms of motivated behaviour that may go unnoticed using conventional assays.

bioRxiv (Cold Spring Harbor Laboratory)
University of Bristol (GB)
University of Bristol, Biotechnology and Biological Sciences Research Council
Good health and well-being
Neurotransmitter Receptor Influence on Behavior
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon